Skip to content
value.today
Total raised
$2 M
2 rounds on record
Latest round
$1 M
Jan 2012
First round on record
Aug 2010
Today
Went public
See the company page

Biolargo, Inc. is listed today as Biolargo Inc.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Biolargo, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2012$1 MNo. 2Under $2 million

Biolargo, Inc.: Raise no. 2, Jan 2012

Investors in this round

32 investors had bought by the notice of May 30, 2012: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
$64,500
Paid to its own people
$300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles K. Dargan · Executive Officer
  • Dennis P Calvert · Executive Officer, Director
  • Joseph L. Provenzano · Executive Officer, Director
  • Kenneth R. Code · Executive Officer, Director
  • Dennis E. Marshall · Director
  • Gary A. Cox · Director
  • John S. Runyan · Director
  • Kent C. Roberts, II · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$1,000,000 offering subject to over-allotment of 15%. Offering closed.”

Signed by Dennis P. Calvert, President. Newest notice filed May 30, 2012. Read the notice at the SEC.

equity, optionsSEC
Aug 2010$1 MNo. 1Under $2 million

Biolargo, Inc.: Raise no. 1, Aug 2010

Investors in this round

41 investors had bought by the notice of Jan 28, 2011: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
$76,100
Paid to its own people
$367,433 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles K Dargan, Ii · Executive Officer
  • Dennis P Calvert · Executive Officer, Director
  • Joseph L Provenzano · Executive Officer, Director
  • Kenneth Reay Code · Executive Officer, Director
  • Dennis E Marshall · Director
  • Gary A Cox · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Wes Larsen · Mission Viejo, CaliforniaSold in CA
  • Mark Fissore · Columbia, South CarolinaSold in CA, FL, and outside the US
  • Bruce Kelber · Orange, CaliforniaSold in CA
  • Jim DeFord · Mission Viejo, CaliforniaSold in CA
  • Trevor Leeds · Newport Beach, CaliforniaSold in AZ, CA, WA

Remarks in the notice

  • On the amounts: “Offering closed”

Signed by Dennis P. Calvert, President. Newest notice filed Jan 28, 2011. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Biolargo Inc., its revenue in fiscal 2025 came from these business segments: Odor-No-More $5.90 million (76%), BioLargo Engineering, Science & Technologies, LLC $2.54 million (33%), BioLargo Canada $90,000 (1%).

    Annual report (SEC XBRL) · Dec 2025

  • Biolargo, Inc. had revenue of up to $1 million when it filed its newest notice of a funding round (May 2012).

    SEC Form D (revenue range) · May 2012

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2012

Products and services#

No products or services of Biolargo, Inc. are on record.

Investors#

No investor of Biolargo, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Largest shareholders today

Institutions holding Biolargo Inc. shares, as of Sep 30, 2026.

As of Sep 30, 2026

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Biolargo, Inc.
NameRoleNamed in
Charles K. DarganExecutive officerMay 2012
Dennis P CalvertExecutive officerMay 2012
Joseph L. ProvenzanoExecutive officerMay 2012
Kenneth R. CodeExecutive officerMay 2012
Charles K Dargan, IiExecutive officerJan 2011
Joseph L ProvenzanoExecutive officerJan 2011
Kenneth Reay CodeExecutive officerJan 2011
Dennis E. MarshallDirectorMay 2012
Dennis P CalvertDirectorMay 2012
Gary A. CoxDirectorMay 2012
John S. RunyanDirectorMay 2012
Joseph L. ProvenzanoDirectorMay 2012
Kenneth R. CodeDirectorMay 2012
Kent C. Roberts, IIDirectorMay 2012
Dennis E MarshallDirectorJan 2011
Gary A CoxDirectorJan 2011
Joseph L ProvenzanoDirectorJan 2011
Kenneth Reay CodeDirectorJan 2011

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.